Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 64

    1.

    Polymer-protein-enhanced fluoroimmunoassay for prostate-specific antigen.

    Mackness BC, Chourb S, Farris LR, McDonald MJ.

    Anal Bioanal Chem. 2009 Nov 8. [Epub ahead of print]PMID: 19898818 [PubMed - as supplied by publisher]Related articles

    2.

    Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.

    Marsillach J, Camps J, Ferré N, Beltran R, Rull A, Mackness B, Mackness M, Joven J.

    BMC Gastroenterol. 2009 Jan 14;9:3.PMID: 19144177 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    High-density lipoprotein: why all the fuss?

    Mackness B, Mackness M.

    Ann Clin Biochem. 2009 Jan;46(Pt 1):5-7. Epub 2008 Nov 17. Review.PMID: 19015220 [PubMed - indexed for MEDLINE]Related articles

    4.

    Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.

    Mastorikou M, Mackness B, Liu Y, Mackness M.

    Diabet Med. 2008 Sep;25(9):1049-55.PMID: 18937674 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.

    Liu Y, Mackness B, Mackness M.

    Free Radic Biol Med. 2008 Sep 15;45(6):743-8. Epub 2008 Jun 6.PMID: 18585453 [PubMed - indexed for MEDLINE]Related articles

    6.

    Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues.

    Marsillach J, Mackness B, Mackness M, Riu F, Beltrán R, Joven J, Camps J.

    Free Radic Biol Med. 2008 Jul 15;45(2):146-57. Epub 2008 Apr 11.PMID: 18440321 [PubMed - indexed for MEDLINE]Related articles

    7.

    Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.

    Guns PJ, Van Assche T, Verreth W, Fransen P, Mackness B, Mackness M, Holvoet P, Bult H.

    Br J Pharmacol. 2008 Feb;153(3):508-16. Epub 2007 Dec 3.PMID: 18059326 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.

    Domagała TB, Łacinski M, Trzeciak WH, Mackness B, Mackness MI, Jakubowski H.

    Cell Mol Biol (Noisy-le-grand). 2006 Dec 31;52(5):4-10.PMID: 17543199 [PubMed - indexed for MEDLINE]Related articles

    9.

    GST CYP and PON1 polymorphisms in farmers attributing ill health to organophosphate-containing sheep dip.

    Povey AC, Jury F, Dippnall WM, Smith AE, Thomson S, Mackness B, Mackness M, Durrington P, Cherry NM.

    Biomarkers. 2007 Mar-Apr;12(2):188-202.PMID: 17536768 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels.

    Phuntuwate W, Suthisisang C, Koanantakul B, Chaloeiphap P, Mackness B, Mackness M.

    Atherosclerosis. 2008 Jan;196(1):122-8. Epub 2007 Apr 6.PMID: 17412348 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease.

    Marsillach J, Ferré N, Vila MC, Lligoña A, Mackness B, Mackness M, Deulofeu R, Solá R, Parés A, Pedro-Botet J, Joven J, Caballeria J, Camps J.

    Clin Biochem. 2007 Jun;40(9-10):645-50. Epub 2007 Feb 3.PMID: 17335791 [PubMed - indexed for MEDLINE]Related articles

    12.

    Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.

    Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J.

    Clin Exp Pharmacol Physiol. 2007 Apr;34(4):347-9.PMID: 17324148 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients.

    van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, Joven J.

    Clin Exp Pharmacol Physiol. 2006 Dec;33(12):1134-7.PMID: 17184491 [PubMed - indexed for MEDLINE]Related articles

    14.

    Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.

    Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.

    J Nephrol. 2006 Nov-Dec;19(6):732-8.PMID: 17173245 [PubMed - indexed for MEDLINE]Related articles

    15.

    Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.

    Mastorikou M, Mackness M, Mackness B.

    Diabetes. 2006 Nov;55(11):3099-103.PMID: 17065348 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.

    Parra S, Alonso-Villaverde C, Coll B, Ferré N, Marsillach J, Aragonès G, Mackness M, Mackness B, Masana L, Joven J, Camps J.

    Atherosclerosis. 2007 Sep;194(1):175-81. Epub 2006 Aug 30.PMID: 16942773 [PubMed - indexed for MEDLINE]Related articles

    17.

    Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.

    Mackness B, Quarck R, Verreth W, Mackness M, Holvoet P.

    Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1545-50. Epub 2006 Apr 20.PMID: 16627808 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Influence of PON1 polymorphisms on the association between serum paraoxonase 1 and homocysteinemia in a general population.

    Murphy MM, Marsillach J, Camps J, Fernández-Ballart J, Mackness B, Mackness M, Ferré N, Joven J.

    Clin Chem. 2006 Apr;52(4):781-2. No abstract available. PMID: 16595840 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.

    Ferré N, Marsillach J, Camps J, Mackness B, Mackness M, Riu F, Coll B, Tous M, Joven J.

    J Hepatol. 2006 Jul;45(1):51-9. Epub 2006 Feb 6.PMID: 16510204 [PubMed - indexed for MEDLINE]Related articles

    20.

    The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.

    Mackness B, McElduff P, Mackness MI.

    J Intern Med. 2005 Oct;258(4):363-8.PMID: 16164576 [PubMed - indexed for MEDLINE]Related articles

    21.

    High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.

    Mackness B, Hine D, McElduff P, Mackness M.

    Atherosclerosis. 2006 Jun;186(2):396-401. Epub 2005 Sep 2.PMID: 16140307 [PubMed - indexed for MEDLINE]Related articles

    22.

    Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep.

    Povey AC, Mackness MI, Durrington PN, Dippnall M, Smith AE, Mackness B, Cherry NM.

    Occup Med (Lond). 2005 Jun;55(4):282-6.PMID: 15982977 [PubMed - indexed for MEDLINE]Related articles

    23.

    Paraoxonase 1 status in the Thai population.

    Phuntuwate W, Suthisisang C, Koanantakul B, Mackness MI, Mackness B.

    J Hum Genet. 2005;50(6):293-300. Epub 2005 May 28.PMID: 15924216 [PubMed - indexed for MEDLINE]Related articles

    24.

    Comparison of paraoxonase 1 measurements in serum and in lithium-heparin-anticoagulated plasma samples.

    Ferré N, Camps J, Marsillach J, Mackness B, Mackness M, Coll B, Tous M, Joven J.

    Clin Chem. 2005 May;51(5):922-3. No abstract available. PMID: 15855675 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.

    Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM.

    Clin Endocrinol (Oxf). 2004 Dec;61(6):760-7.PMID: 15579192 [PubMed - indexed for MEDLINE]Related articles

    26.

    Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.

    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.

    Circulation. 2004 Nov 16;110(20):3259-69. Epub 2004 Nov 8.PMID: 15533870 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

    Mackness M, Mackness B.

    Free Radic Biol Med. 2004 Nov 1;37(9):1317-23. Review.PMID: 15454272 [PubMed - indexed for MEDLINE]Related articles

    28.

    Paraoxonase polymorphisms and coronary heart disease.

    Durrington PN, Mackness B, Mackness MI.

    Lancet. 2004 Aug 14-20;364(9434):579-80; author reply 580. No abstract available. PMID: 15313350 [PubMed - indexed for MEDLINE]Related articles

    29.

    The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.

    Mackness MI, Durrington PN, Mackness B.

    Am J Cardiovasc Drugs. 2004;4(4):211-7. Review.PMID: 15285696 [PubMed - indexed for MEDLINE]Related articles

    30.

    Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.

    Mackness M, Durrington P, Mackness B.

    Curr Opin Lipidol. 2004 Aug;15(4):399-404. Review.PMID: 15243212 [PubMed - indexed for MEDLINE]Related articles

    31.

    Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.

    Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M.

    Biochem Biophys Res Commun. 2004 Jun 4;318(3):680-3.PMID: 15144891 [PubMed - indexed for MEDLINE]Related articles

    32.

    Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure.

    Hernández AF, Mackness B, Rodrigo L, López O, Pla A, Gil F, Durrington PN, Pena G, Parrón T, Serrano JL, Mackness MI.

    Hum Exp Toxicol. 2003 Nov;22(11):565-74.PMID: 14686479 [PubMed - indexed for MEDLINE]Related articles

    33.

    Paraoxonase in Persian Gulf War veterans.

    Hotopf M, Mackness MI, Nikolaou V, Collier DA, Curtis C, David A, Durrington P, Hull L, Ismail K, Peakman M, Unwin C, Wessely S, Mackness B.

    J Occup Environ Med. 2003 Jul;45(7):668-75.PMID: 12855907 [PubMed - indexed for MEDLINE]Related articles

    34.

    Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.

    Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M.

    Circulation. 2003 Jun 10;107(22):2775-9. Epub 2003 May 19.PMID: 12756158 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.

    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.

    Circulation. 2003 Apr 1;107(12):1640-6. Epub 2003 Mar 24.PMID: 12668499 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Paraoxonase and coronary heart disease.

    Mackness MI, Mackness B, Durrington PN.

    Atheroscler Suppl. 2002 Dec;3(4):49-55. Review.PMID: 12573363 [PubMed - indexed for MEDLINE]Related articles

    37.

    Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.

    Mackness B, Durrington P, Povey A, Thomson S, Dippnall M, Mackness M, Smith T, Cherry N.

    Pharmacogenetics. 2003 Feb;13(2):81-8.PMID: 12563177 [PubMed - indexed for MEDLINE]Related articles

    38.

    The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.

    Sangvanich P, Mackness B, Gaskell SJ, Durrington P, Mackness M.

    Biochem Biophys Res Commun. 2003 Jan 10;300(2):501-6.PMID: 12504112 [PubMed - indexed for MEDLINE]Related articles

    39.

    The hunt for nutritional and pharmacological modulators of paraoxonase.

    Durrington PN, Mackness B, Mackness MI.

    Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1248-50. No abstract available. PMID: 12171781 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The paraoxonase gene family and coronary heart disease.

    Mackness B, Durrington PN, Mackness MI.

    Curr Opin Lipidol. 2002 Aug;13(4):357-62. Review.PMID: 12151850 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effect of organophosphate intoxication on human serum paraoxonase.

    Sözmen EY, Mackness B, Sözmen B, Durrington P, Girgin FK, Aslan L, Mackness M.

    Hum Exp Toxicol. 2002 May;21(5):247-52.PMID: 12141395 [PubMed - indexed for MEDLINE]Related articles

    42.

    Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.

    Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI.

    Eur J Clin Invest. 2002 Apr;32(4):259-64.PMID: 11952811 [PubMed - indexed for MEDLINE]Related articles

    43.

    Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip.

    Cherry N, Mackness M, Durrington P, Povey A, Dippnall M, Smith T, Mackness B.

    Lancet. 2002 Mar 2;359(9308):763-4.PMID: 11888590 [PubMed - indexed for MEDLINE]Related articles

    44.

    Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

    Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E, Roberts C, Durrington PN, Mackness MI.

    Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1451-7.PMID: 11557671 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Paraoxonase and atherosclerosis.

    Durrington PN, Mackness B, Mackness MI.

    Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):473-80. Review.PMID: 11304460 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Hydrolysis of platelet-activating factor by human serum paraoxonase.

    Rodrigo L, Mackness B, Durrington PN, Hernandez A, Mackness MI.

    Biochem J. 2001 Feb 15;354(Pt 1):1-7.PMID: 11171072 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome.

    Mackness B, Durrington PN, Mackness MI.

    Biochem Biophys Res Commun. 2000 Sep 24;276(2):729-33.PMID: 11027539 [PubMed - indexed for MEDLINE]Related articles

    48.

    How high-density lipoprotein protects against the effects of lipid peroxidation.

    Mackness MI, Durrington PN, Mackness B.

    Curr Opin Lipidol. 2000 Aug;11(4):383-8. Review.PMID: 10945720 [PubMed - indexed for MEDLINE]Related articles

    49.

    Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.

    Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI.

    Clin Sci (Lond). 2000 Mar;98(3):355-63.PMID: 10677395 [PubMed - indexed for MEDLINE]Related articles

    50.

    Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits.

    Mackness M, Boullier A, Hennuyer N, Mackness B, Hall M, Tailleux A, Duriez P, Delfly B, Durrington P, Fruchart JC, Duverger N, Caillaud JM, Castro G.

    Biochem Biophys Res Commun. 2000 Mar 5;269(1):232-6. Erratum in: Biochem Biophys Res Commun 2000 Apr 13;270(2):676. Bouiller A [corrected to Boullier A]. PMID: 10694505 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...